Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation (vol 17, pg 1193, 2015)

Autor: Procopio, Mg, Cseke, Laszlo, Al Labban, D, Kim, De, Bordignon, P, Sh, Jo, Goruppi, S, Menietti, E, Stall, P, Ala, U, Provero, P, Hoetzenecker, W, Neel, V, Kilarski, Ww, Swartz, Ma, Brisken, C, Lefort, K, Dotto, Gp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::1d44f651765f2763b55e0cb3bebb9fa1
http://hdl.handle.net/2318/1742476

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B.

Autor: Al Labban D; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland., Jo SH; Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA., Ostano P; Cancer Genomics Laboratory, Edo and Elvo Tempia Valenta Foundation, Biella, Italy., Saglietti C; Department of Pathology, and., Bongiovanni M; Department of Pathology, and., Panizzon R; Department of Dermatology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dotto GP; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.; Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2018 Jun 01; Vol. 128 (6), pp. 2581-2599. Date of Electronic Publication: 2018 May 14.